View Source

The GeCIP Board is tasked with overseeing and steering GeCIP. It is comprised of:

representatives from funders (National Institute for Health Research, Wellcome Trust, Medical Research Council, Cancer Research UK);
a representative from the Genomics England Scientific Advisory Committee;
patient representative(s);
a representative from each of the devolved nations
and a representative from each of the Cancer, Rare Diseases, and Cross-Cutting arms of GeCIP, as decided by the GeCIP Steering Committee.

Membership

Its current membership is as follows

Member name	Position
Kay Davies	Chair
Mark Caulfield	Genomics England, Chief Scientist and Deputy Chair
Sue Hill	NHS England, Chief Scientific Officer
Mark Bale	DH/NIHR
Michael Parker	Ethic Advisory Committee Representative
Michael Dunn	Wellcome Trust
Nathan Richardson	Medical Research Council
Maria A Cerone	Cancer Research UK
Tom Barlow	Devolved Nations Representative for Scotland
Jon Bisson	Devolved Nations Representative for Wales
Ian Young	Devolved Nations Representative for Northern Ireland
Colin Cooper	Cross-Cutting GeCIP Domain Representative
Chrissie Thirlwell	Cancer GeCIP Domain Representative
Henry Houlden	Rare diseases GeCIP Domain Representative
Leanne Leriche	Participant Panel Representative
Alison Fox	Participant Panel Representative
Dave McCormick	Participant Panel Representative